Objective: The prognostic role of electroencephalography during and after targeted temperature management in postcardiac arrest patients, relatively to other predictors, is incompletely known. We assessed performances of electroencephalography during and after targeted temperature management toward good and poor outcomes, along with other recognized predictors.
C linicians are increasingly confronted with expectations to provide early, reliable risk stratification of outcome in comatose patients after cardiac arrest (CA). Current recommendations emphasize the need of a multimodal approach (1) (2) (3) , where available prognosticators target identification of poor outcome patients (4) . There is therefore an important need to learn about the value of readily available tools orienting toward good outcome.
Electroencephalography (EEG) represents one of the most frequently used prognosticators (5) . Several groups have repetitively highlighted its value for prediction of poor prognosis (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . In addition, some studies have highlighted that background continuity (6, 16, 17) and reactivity (18) can identify patients with good outcome. However, these analyses did not systematically examine the role of early versus late (after return to normothermia and off sedation) features, nor the place of EEG in comparison with other predictors.
We aimed to explore the role of specific EEG features for good and poor outcome prognostications and to compare it to the performance of other predictors, considering both early and later assessments. Furthermore, we intended to validate a recently proposed EEG scoring system (14) , based on the American Clinical Neurophysiology Society (ACNS) EEG nomenclature (19) .
METHODS

Design, Patients, and Settings
This cohort study includes consecutive adults (> 18 yr old) receiving targeted temperature management (TTM) in the ICU for hypoxic-ischemic encephalopathy following CA, with both early (during targeted TTM) and late (after return to normothermia and off sedation, 48-72 hr after admission) EEG, and functional outcome at 3 months. Only subjects with missing EEG data were not included. Patients were identified through existing, prospective registries of the Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland, between April 2009 and March 2016, and the Mayo Clinic, Rochester, MN, between November 2009 and March 2014, approved by their institutional review board; consents were waived (no intervention).
Procedures and Variables
All patients received 24 hours TTM: mild hypothermia to 33-34°C (20) or controlled normothermia at 36°C (21) , under standard sedation. At the CHUV, midazolam (0.1 mg/kg/hr) or propofol (less frequently; 2-3 mg/kg/hr) and fentanyl (1.5 µg/kg/hr) infusions were given during the first 24-36 hours; curare was administered for shivering. At the Mayo Clinic, the protocol comprised midazolam infusions (0.015 mg/kg/hr) or alternatively, propofol (1-2 mg/kg/hr). Fentanyl was perfused up to 1 µg/kg/hr. Curare was given as needed. Patients with myoclonus or EEG seizures were treated with nonsedating anticonvulsants (valproate and levetiracetam).
Video EEGs (CHUV: Viasys, Madison, WI; Mayo clinic: XLTEK, Pleasanton, CA) using 21 electrodes according to the 10-20 system were performed continuously for 24-48 hours, starting as soon as possible after CA, or over 20-30 minutes during the first 9-30 hours and thereafter, within 72 hours after return to normothermia and off sedation. In both approaches, scoring was performed during and after TTM and sedation weaning, at the times of reactivity assessment, tested by applying repetitive auditory, visual, and nociceptive stimuli (finger compression, bilateral nipple pinching if no reactivity seen before) (12, 15) . EEG was categorized by certified interpreters (A.O.R., D.F.T.Q., J.N., J.W.B.) for the presence/absence of three dichotomous features: 1) reactivity (recognizable background with reproducible changes in amplitude or frequency within 1-2 s of any stimulation, excluding stimulus-induced rhythmic, periodic or ictal discharges [22, 23] , and muscle artifacts); 2) spontaneous discontinuous pattern (suppressions of at least 10% of the recording [19] ); and 3) repetitive epileptiform activity (periodic or rhythmic spikes, sharp waves, or spike waves [9, 24] occurring at least over 10% of the record). Scoring, blinded to outcome, was prospective at the CHUV and retrospective at the Mayo Clinic. For this study, recordings performed before 2013 were rescored to comply with the ACNS nomenclature (19) (that was used since then), using registries' data and analysis of raw traces in unclear situations (< 5%, especially for continuity). A distinction between burst suppression and discontinuity was not definitely retrievable in all cases without epileptiform components, but suppression less than 10 μV was identified as "flat recording," and reactivity scoring did not change across time.
Within 96 hours from CA, at normothermia and off sedation, patients were serially examined; best results were considered for this analysis. Pupillary and corneal reflexes were categorized as present versus bilaterally absent; response to pain as flexion or better versus extension or none (3). Early myoclonus was considered if appearing within 24 hours after sedation discontinuation. After TTM, cortical responses of somatosensory-evoked potentials (SSEPs) were categorized as present versus bilaterally absent. Serum neuron-specific enolase (NSE) was measured within the first 72 hours and assessed through automated immunofluorescent assays (Thermo Scientific Brahms NSE Kryptor; Thermo Fisher Scientific, Hennigsdorf, Germany); results of peak values were categorized using a threshold of 75 µg/L (15).
Decision to withdraw ICU support was made by interdisciplinary consensus within 10 days after CA, according to a prespecified multimodal approach (9) . Importantly, early EEG scoring was not used for this decision.
Data Collection and Outcome Assessment
Demographic and clinical variables were collected prospectively using Utstein's recommendations (25) ; CA etiology was dichotomized as cardiac versus noncardiac, and initial heart rhythm as ventricular fibrillation or tachycardia versus asystole or pulseless activity. At the CHUV, time to return of spontaneous circulation was estimated on patient's admission. Best neurologic outcome within 3 months was assessed blinded to clinical results: at the CHUV prospectively through a telephone interview, at the Mayo Clinic through charts review (patients were routinely seen at 3 mo), using Cerebral Performance Categories (CPCs) (26); CPC 1-2 defined good recovery (4) .
Statistics
Contingency tables were tested through Fisher exact or chisquare tests and normally distributed variables with two-tailed t tests, as needed. Two outcomes were considered: good functional outcome (CPC 1-2) and mortality. Sensitivity and positive predictive values (PPVs) were calculated for good outcome, and sensitivity and false positive rates (FPRs, 1 -specificity) were calculated for mortality (4) . Accuracies (true negatives and positives/all patients) were calculated for variables with PPV of greater than 70% for good outcome and FPR less than 5% for mortality, with 95% CIs (binomial distribution). We tested separately PPV for good outcomes considering "benign EEG patterns" (continuous, not suppressed background with reactivity, without epileptiform discharges) and FPR for mortality considering "highly malignant patterns" (suppression or burst suppression, with or without periodic discharges), as recently defined (14) using the ACNS nomenclature (19) . Backward stepwise logistic regression analyses were conducted using variables with PPV of greater than 70% for a good outcome or FPR less than 5% for mortality, adjusted for treating centers; calibration was assessed with a Hosmer-Lemeshow test. Calculations were performed using STATA software, version 12 (StataCorp, College Station, TX). 
RESULTS
We studied 260 patients at the CHUV (134 overlapping with [15] ) and 97 at the Mayo Clinic (62 overlapping with [27] EEG including reactivity assessment was performed 17.9 ± 6.2 hours after CA (in 236 patients, 91%, within 24 hr). Table 2 summarizes predictive performances for good outcome (CPC 1-2). Three variables showed a PPV of greater than 70%: early EEG reactivity and continuity and flexor or better motor response. All features had sensitivities greater than 80%; EEG reactivity and motor reaction showed the highest accuracy. The multivariable logistic regression confirmed that the three were independently related to favorable prognosis ( Table 3) . Early and late benign EEG had also high PPV. Table 4 shows mortality prediction (Supplemental Tables 1  and 2 , Supplemental Digital Content 1, http://links.lww.com/ CCM/C426: stratification between previously published and new patients). Several variables had an FPR of less than 5%; Although sensitivity was below 50% for nearly all, EEG reactivity stood out (especially early EEG, displaying the highest accuracy). Early and late highly malignant EEG also showed very low FPR. Multivariable analysis identified early EEG reactivity and epileptiform discharges and late EEG reactivity, as independently related to mortality ( Table 5 ). Figure 1 illustrates the predictive performance of the principal variables toward the two main outcomes.
DISCUSSION
Several studies evaluated predictors of poor prognosis after CA, but our analysis is one of the few also assessing indicators of good outcome, and explores prognosticators during and after TTM in relation to both outcomes. It shows that EEG reactivity during TTM and sedation has the highest accuracy for both good and poor outcomes. It also highlights the prognostic value for good outcome when the motor response to pain is flexion or better. Furthermore, a predefined benign EEG background has a high PPV for good outcome, whereas a highly malignant pattern has a very low FPR for mortality, both during and after TTM (14) .
EEG Reactivity
During TTM, reactivity seems the most robust discriminator between good and poor outcomes and is independently related to them. Reactivity during TTM correlates with neuronal injury reflected by NSE (12) . Although mild therapeutic hypothermia should not exert a major impact on EEG (28), pharmacologic sedation may influence background continuity (6, 15, 16) . Epileptiform features, which indeed do not significantly correlate with neuronal injury markers (12), showed lower sensitivity for mortality when compared with reactivity and lower specificity for good outcome. We recognize that reactivity has an imperfect interrater reliability (29, 30) , with a heterogeneous prevalence at our two centers, even if both are familiar with the stimulus type (nipples pinching) that seems to be most sensitive (31) .
Timing of EEG Assessment
EEG has been traditionally used after TTM and off sedation (9, 10, 32) : lack of reactivity forecasts unfavorable prognosis (9, 10), similarly to low voltage (< 20 µV), suppressed or burst-suppressed background (6, 14) , or burst suppression with identical bursts (8) . Epileptiform features were also related to poor outcome (9) . These features are found in current prognostic recommendations (1) .
Recently, increasing attention was directed toward EEG recorded during TTM and sedation (24): suppressed or lowvoltage background shows higher correlation with poor outcome (6, 16, 33, 34) , similarly to lack of reactivity (11, 15) , and epileptiform features (12, 13, 34) . Additionally, and innovatively (4), EEG has been reported to herald good outcome if a continuous background and normal voltage are seen at 12-24 hours (6, 16), or showing reproducible reactivity (18) . It is possible that recordings performed early after CA and standardized conditions may be exposed to less confounders (comorbidities such as infections, vigilance, and comedications).
This study validates recent findings of the TTM trial EEG analysis (14) on predefined benign and highly malignant patterns, confirming the robustness of prediction for poor and good outcomes after return of normothermia, albeit with slightly higher FPR, probably reflecting a less standardized reading and the considerably greater number of patients, better corresponding to real clinical practice. Additionally, we expanded the usefulness of this approach into recordings obtained during TTM and sedation.
Comparison With Previous Studies on Clinical EEG
The CHUV reactivity analyses (11, 18) were single-center, including 90 patients, with only few other predictors. The Mayo Clinic study (17) , including 54 patients, did not evaluate other variables and assigned EEG into one of three predefined categories, preventing more granular analyses. The Yale series (6) included 100 patients and did not consider biochemical markers or SSEP. The Belgian assessment (33) involved 92 patients, also used a composite EEG scoring, and did not analyze in detail EEG after sedation, nor other prognosticators. A study from Pittsburgh on EEG counterparts of myoclonus included 65 patients; it did not report on a multimodal approach (34) . The Dutch two-center cohort was large (277 patients); however, EEG scorings were also composite, and EEG reactivity, corneal reflexes, or NSE were not addressed. Finally, the TTM trial analysis (14) , with 103 subjects from European hospitals, was limited to normothermia, not confirming the value of low voltage (6, 16) ; other prognosticators were not addressed. Quantitative EEG receives growing interest (29, 35) , but this approach is still limited by generalizability (4).
Although our study appears in line with these previous findings, it adds new information. It includes the largest number of patients, from two relatively heterogeneous cohorts in terms of EEG recordings, CA types, sedation, TTM, and neurophysiologic, clinical, and biochemical features (Table 1 ), in distinct locations with different practical approaches. This should reinforce generalizability of the findings. It validates outside a rigid study setting not only a recently proposed EEG scoring following the ACNS nomenclature (14, 30, 36) but also analyzes core EEG features (reactivity, continuity, and epileptiform transients), allowing detailed understanding of the prognostic role of each for both poor and, importantly, good outcomes. Both sites used a predefined protocol for discontinuation of ICU measures, rendering identification of items potentially biased by the self-fulfilling prophecy more straightforward (4).
Motor Reaction
The remarkable prognostication performance of responses better than extension for identification of good prognosis may appear somewhat surprising. Extension or lack of movements was found to forecast poor prognosis before the hypothermia era (3) but was strongly questioned after convergent reports of unacceptable high FPRs in patients undergoing TTM (and sedation) (9, (37) (38) (39) : it is thus not mentioned in current recommendations (1), and false positivity is high (15.2%) in this study. Our results indicate that a flexor or better reaction shortly after TTM independently heralds favorable outcome in a significant proportion of patients, confirming a previous observation (6) . This may represent a revival of this clinical sign to specifically detect favorable recovery, in a context where nearly all prognosticators are directed toward identification of poor prognosis.
Limitations
First, EEG scoring occurred prospectively at the CHUV but retrospectively-albeit blinded-at the Mayo Clinic; this may explain some heterogeneity of findings. Second, we included both continuous and routine EEG recordings. Some groups advocate continuous EEG (6, 16) as electrical activity evolves and seizures may be detected (7) . This technique is however not likely to be widely available, and routine EEGs, including stimulations for reactivity, seem to offer comparable information (40) , at lower costs (27) . Third, EEG assessment times were not strictly uniform, and prevalence of EEG reactivity and continuity, brainstem reflexes, and motor reaction differed across centers. Although heterogeneous data ascertainment is possible, this reflects the observational design with different sedation policies (higher doses at CHUV) and patients' profile (somewhat worse outcome at CHUV). Our findings may thus be generalizable to other settings. Furthermore, multivariable models were adjusted for centers; patients at CHUV had worse outcomes on the raw data but had higher chance of good outcome in the analysis adjusted for poor prognostic features. Reasons for this discrepancy are unclear and may in part reflect the subjectivity of the CPC, which nevertheless is validated. Importantly, the difference between centers was significant but almost marginal (CI approaching 1), and mortality was not different. Fourth, several EEG items related to the ACNS nomenclature were inferred retrospectively for records preceding 2013; due to this, low voltage more than 10 µV was not systematically considered as incompatible with benign, as opposed to (14); Figure 1 . Accuracy toward good outcome (grey bars) and mortality (black bars) of predictors with a positive predictive value greater than 70% for good outcome and false positive rate less than 5% for mortality. EEG = electroencephalography, GCS = Glasgow Coma Score, NSE = neuronspecific enolase, SSEP = somatosensory-evoked potential.
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Fifth, we did not analyze brain imaging, used unsystematically. Sixth, outcome assessment was not uniform, and occurred at 3 (but not 6) months, reflecting the centers' practices in those years. Finally, although cause of death and decisions to withdraw life support were not specifically recorded, the latter were always discussed after clinical examinations off sedation, and EEG scoring occurred blindly toward outcome; therefore, despite having being available to clinicians, early EEG is unlikely to have been affected by the self-fulfilling prophecy.
CONCLUSION
It is of outmost importance to always formulate a prognosis after carefully evaluating all available information from different sources, in order to minimize risks of false poor prediction (1, 2, 4). Although current guidelines still rely on relatively late EEG (1, 3), early EEG represents a valuable tool to identify patients both with good and poor prognoses. Thus, information provided by EEG has important practical implications but should never be used alone for prognostication.
